Treatment Planning Software Support Radiotherapy Systems
|
By MedImaging International staff writers Posted on 01 Jul 2021 |

Image: The CyberKnife S7 System (photo courtesy of Accuray)
A novel software solution enables clinicians to plan treatment plans for CyberKnife and conventional radiation therapy (RT) devices.
The RaySearch Laboratories AB (Stockholm, Sweden) RayStation is a unified treatment planning system (TPS) that supports Accuray (Sunnyvale, CA) CyberKnife M6 and S7 robotic stereotactic body RT (SBRT) systems, as well as other RT systems. It is compatible with all collimator types (fixed, Iris Variable Aperture, and InCise multileaf collimators). The software improves workflows, supports multiple RT prescriptions, multiple GPUs in photon Monte Carlo dose calculation, faster optimization, and more efficient memory allocation.
A new workflow feature defines tolerance tables, which are specifications of permitted deviations from various machine settings. The tolerance tables can be selected during planning and exported with the plan, which simplifies treatment delivery. Additional features include indication-specific motion tracking and adaptation with Accuray Synchrony technology; delivery of non-coplanar, isocentric, or non-isocentric treatment beams from potentially thousands of different angles; fast, accurate dose calculation that enables dose adjustment in real-time; and deformable registration and adaptive planning.
“The introduction of RayStation for the CyberKnife Systems will make it easier for providers with multiple radiotherapy systems to adopt and integrate Accuray technology seamlessly into their clinical operation,” said Suzanne Winter, chief commercial officer and senior vice president of R&D at Accuray. “Accuray CyberKnife, Radixact, and TomoTherapy systems interface with both RayStation and the Accuray Precision TPS, enabling our customers to optimize their experience and use of our technology over the long-term.”
“With the addition of CyberKnife planning support, RayStation becomes the first treatment planning system to support all major photon linacs,” said Björn Hårdemark, MSc, deputy CEO at RaySearch. “Both Radixact and CyberKnife are extremely versatile delivery platforms, and the ability to plan for these systems in parallel with conventional linacs makes it possible to easily assess which patients benefit the most from the capabilities of the Accuray systems.”
The CyberKnife System with the Synchrony motion synchronization technology uses artificial intelligence (AI) to adapt radiation delivery in real-time to patient and/or tumor movement throughout the course of treatment. The system's robotic design facilitates RT from potentially thousands of unique angles, maximizing radiation dose to the tumor and minimizing dose to surrounding healthy tissues.
Related Links:
RaySearch Laboratories AB
Accuray
The RaySearch Laboratories AB (Stockholm, Sweden) RayStation is a unified treatment planning system (TPS) that supports Accuray (Sunnyvale, CA) CyberKnife M6 and S7 robotic stereotactic body RT (SBRT) systems, as well as other RT systems. It is compatible with all collimator types (fixed, Iris Variable Aperture, and InCise multileaf collimators). The software improves workflows, supports multiple RT prescriptions, multiple GPUs in photon Monte Carlo dose calculation, faster optimization, and more efficient memory allocation.
A new workflow feature defines tolerance tables, which are specifications of permitted deviations from various machine settings. The tolerance tables can be selected during planning and exported with the plan, which simplifies treatment delivery. Additional features include indication-specific motion tracking and adaptation with Accuray Synchrony technology; delivery of non-coplanar, isocentric, or non-isocentric treatment beams from potentially thousands of different angles; fast, accurate dose calculation that enables dose adjustment in real-time; and deformable registration and adaptive planning.
“The introduction of RayStation for the CyberKnife Systems will make it easier for providers with multiple radiotherapy systems to adopt and integrate Accuray technology seamlessly into their clinical operation,” said Suzanne Winter, chief commercial officer and senior vice president of R&D at Accuray. “Accuray CyberKnife, Radixact, and TomoTherapy systems interface with both RayStation and the Accuray Precision TPS, enabling our customers to optimize their experience and use of our technology over the long-term.”
“With the addition of CyberKnife planning support, RayStation becomes the first treatment planning system to support all major photon linacs,” said Björn Hårdemark, MSc, deputy CEO at RaySearch. “Both Radixact and CyberKnife are extremely versatile delivery platforms, and the ability to plan for these systems in parallel with conventional linacs makes it possible to easily assess which patients benefit the most from the capabilities of the Accuray systems.”
The CyberKnife System with the Synchrony motion synchronization technology uses artificial intelligence (AI) to adapt radiation delivery in real-time to patient and/or tumor movement throughout the course of treatment. The system's robotic design facilitates RT from potentially thousands of unique angles, maximizing radiation dose to the tumor and minimizing dose to surrounding healthy tissues.
Related Links:
RaySearch Laboratories AB
Accuray
Latest Nuclear Medicine News
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
Advanced MRI System Detects Impaired Cardiac Oxygen Use in Minutes
Early identification of cardiac dysfunction remains challenging because current methods to evaluate myocardial oxygen use are invasive or impractical for routine care. Delays in detecting impaired oxygen... Read more
AI-Enhanced MRI Improves Image Quality in Arrhythmia Patients
Arrhythmia, an irregular heartbeat, can degrade cardiac magnetic resonance imaging by inducing motion and mistriggering. Accurate, repeatable assessment of left ventricular function is essential for treatment... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







